Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XNT
|
||||
Former ID |
DIB004006
|
||||
Drug Name |
BMS-A
|
||||
Synonyms |
BMS-A; CCR2 antagonists (inflammatory/metabolic diseases); CCR2 antagonists (inflammatory/metabolic diseases), Bristol-Myers Squibb
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543887] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H10ClF3N2O3
|
||||
Canonical SMILES |
FC(F)(c1cc(C(=O)NCC(=O)N[C@@H]2[C@@H](C[C@@H](CC2)N(C(C<br />)C)C)CS(=O)(=O)C(C)C)ccc1)F
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | C-C chemokine receptor type 2 | Target Info | Antagonist | [543887] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.